Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and Efficacy of Tinostamustine in a Subpopulation of Patients With Relapsed/Refractory Hodgkin Lymphoma From a Phase I Trial.
Sureda A, Pinto A, Ghesquières H, Morschhauser F, Tournilhac O, Mutsaers P, Zijlstra JM, De Filippi R, Hilgier K, Manamley N, Janik T, Zinzani PL. Sureda A, et al. Among authors: de filippi r. Hematol Oncol. 2025 Jan;43(1):e70000. doi: 10.1002/hon.70000. Hematol Oncol. 2025. PMID: 39617826 Free PMC article. Clinical Trial.
Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma.
Corazzelli G, Angrilli F, D'Arco A, Ferrara F, Musto P, Guarini A, Cox MC, Stelitano C, Storti S, Iannitto E, Falorio S, Califano C, Amore A, Arcamone M, De Filippi R, Pinto A. Corazzelli G, et al. Among authors: de filippi r. Br J Haematol. 2013 Jan;160(2):207-15. doi: 10.1111/bjh.12120. Epub 2012 Nov 20. Br J Haematol. 2013. PMID: 23167437 Free article.
Long-term efficacy and safety of dose-dense and dose-intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15-year follow-up of the ABVDDD-DI phase II study.
Corazzelli G, Cuccaro A, Morelli E, Arcamone M, De Chiara A, Paccone A, Petrillo A, Ibello F, Aversa C, Esposito M, Volzone F, Saggese M, Capobianco G, Sarno S, Sirica L, Crisci S, De Filippi R, Pinto A. Corazzelli G, et al. Among authors: de filippi r. Br J Haematol. 2024 Oct;205(4):1383-1388. doi: 10.1111/bjh.19646. Epub 2024 Aug 1. Br J Haematol. 2024. PMID: 39091109 Clinical Trial.
Aging and the hemopoietic system.
Pinto A, De Filippi R, Frigeri F, Corazzelli G, Normanno N. Pinto A, et al. Among authors: de filippi r. Crit Rev Oncol Hematol. 2003 Oct 15;48(Suppl):S3-S12. doi: 10.1016/j.critrevonc.2003.06.006. Crit Rev Oncol Hematol. 2003. PMID: 14563515 Review.
Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas.
Corazzelli G, Frigeri F, Arcamone M, Aloj L, Capobianco G, Becchimanzi C, Morelli E, Volzone F, Marcacci G, Russo F, De Filippi R, Lastoria S, Pinto A. Corazzelli G, et al. Among authors: de filippi r. Eur J Haematol. 2011 Dec;87(6):547-53. doi: 10.1111/j.1600-0609.2011.01683.x. Epub 2011 Jul 31. Eur J Haematol. 2011. PMID: 21752099 Free PMC article.
86 results